ARCHIVES

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

This article is from The Cancer Letter archive.

Vol. 10 No. 33 | August 31, 1984

Download PDF Visit The Full Archive

Related Articles

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005